Plain-English translation of NCT06069622 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing semaglutide, a medication that helps people lose weight, to understand why some people's blood pressure improves while others' doesn't. Researchers want to find out if a specific gene variant affects how well the medication works for lowering blood pressure and losing weight in overweight or obese adults.
While this medication is very effective at helping people lose weight and improving heart health, doctors have noticed that it doesn't lower blood pressure equally in everyone. This study aims to discover whether a person's genes can predict who will benefit most from this treatment, which could eventually help doctors personalize obesity care.
You likely qualify if…
You likely don't qualify if…
You will take semaglutide as prescribed by your doctor while researchers monitor your blood pressure, weight, and metabolic health. The study will involve screening visits to confirm you qualify, blood tests to check your baseline health and genes, and regular follow-up visits to measure how the medication affects your blood pressure and weight. The exact duration and number of visits will depend on the study protocol.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States